Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Nanning, 530028, Guangxi, China.
Guangxi Collaborative Innovation Center for Biomedicine, Guangxi Medical University, Nanning, 530021, Guangxi, China.
BMC Infect Dis. 2021 Feb 8;21(1):160. doi: 10.1186/s12879-021-05854-w.
The widespread use of antiretroviral therapy (ART) has resulted in the development of transmitted drug resistance (TDR), which reduces ART efficacy. We explored TDR prevalence and its associated risk factors in newly diagnosed individuals in Guangxi.
We enrolled 1324 participants who were newly diagnosed with HIV-1 and had not received ART at voluntary counselling and testing centres (VCT) in Guangxi, China, who had not received ART. Phylogenetic relationship, transmission cluster, and genotypic drug resistance analyses were performed using HIV-1 pol sequences. We analysed the association of demographic and virological factors with TDR.
In total, 1151 sequences were sequenced successfully, of which 83 (7.21%) showed evidence of TDR. Multivariate logistic regression analysis revealed that there was significant difference between the prevalence of TDR and unmarried status (adjusted odds ratio (aOR) = 2.41, 95% CI: 1.23-4.71), and CRF08_BC subtype (aOR = 2.03, 95% CI: 1.13-3.64). Most cases of TDR were related to resistance to non-nucleoside reverse transcriptase inhibitors (4.87%) and V179E was the most common mutation detected. We identified a total of 119 HIV transmission clusters (n = 585, 50.8%), of which 18 (15.1%) clusters showed evidence of TDR (36, 41.86%). Three clusters were identified that included drug-resistant individuals having a transmission relationship with each other. The following parameters were associated with TDR transmission risk: Unmarried status, educational level of junior high school or below, and CRF08_BC subtype may be a risk of the transmission of TDR.
Our findings indicated that moderate TDR prevalence and highlighted the importance of continuous TDR monitoring and designing of strategies for TDR mitigation.
抗逆转录病毒疗法(ART)的广泛应用导致了传播性耐药(TDR)的发展,从而降低了 ART 的疗效。我们在广西探索了新诊断的个体中 TDR 的流行情况及其相关的危险因素。
我们招募了 1324 名在广西自愿咨询和检测中心(VCT)新诊断为 HIV-1 且未接受 ART 的个体,这些个体未接受 ART。使用 HIV-1 pol 序列进行系统发育关系、传播簇和基因型耐药分析。我们分析了人口统计学和病毒学因素与 TDR 的关联。
共成功测序了 1151 个序列,其中 83 个(7.21%)显示出 TDR 的证据。多变量逻辑回归分析显示,TDR 的流行率与未婚状态(调整后的优势比[aOR] = 2.41,95%可信区间:1.23-4.71)和 CRF08_BC 亚型(aOR = 2.03,95%可信区间:1.13-3.64)之间存在显著差异。大多数 TDR 病例与对非核苷类逆转录酶抑制剂的耐药性有关(4.87%),最常见的突变是 V179E。我们共鉴定了 119 个 HIV 传播簇(n = 585,50.8%),其中 18 个(15.1%)簇显示出 TDR 的证据(36,41.86%)。有 3 个簇被鉴定为包含彼此具有传播关系的耐药个体。以下参数与 TDR 传播风险相关:未婚状态、初中及以下学历,以及 CRF08_BC 亚型可能是 TDR 传播的风险因素。
我们的研究结果表明,TDR 的流行率适中,强调了持续监测 TDR 和设计 TDR 缓解策略的重要性。